Interview: Gaby Murphy – Managing Director, EMD Serono, Canada
At the 350th anniversary of the company, Gaby Murphy, EMD Serono’s managing director, gives an insight into the turning point for the affiliate in 2017 with three new Health Canada…
Servier Canada Inc is the Canadian affiliate of The Servier Research Group, a leading French research based organisation, specializing in ethical pharmaceuticals.
In the short span of fifty five years, the Servier Research Group has developed in stature from a family-owned, provincial pharmacy employing nine people to a multi-national operation with over 20,000 employees, including 3,000 in R&D, yet the Company is still privately-owned and is still passionately and permanently committed to remaining independent.
In Canada, Servier’s activities commenced in February 1978 in a modest location in Pointe-Claire, Quebec with a total staff of three employees. Within a month of its opening, a Sales supervisor and seven sales representatives were recruited and working in the region of Quebec. From 1985-1991, Servier Canada continued to gradually expand its presence across Canada, with growth in both its size of sales force and the number of head office employees. By 1994, the Company had moved to new premises in Laval, Quebec, where its current facility resides.
Servier Canada is committed to the investment in research and development and was proud to join Canada’s Research Based Pharmaceutical Companies (Rx&D) in 1995.
Contact
At the 350th anniversary of the company, Gaby Murphy, EMD Serono’s managing director, gives an insight into the turning point for the affiliate in 2017 with three new Health Canada…
Investissement Québec (IQ) contributed to the completion of 65 international projects in 2017 and hosts Pfizer, Sanofi, and Merck amongst over 160 IT companies, employing over 5,400 workers. Pierre Gabriel…
Imran Ali, senior manager of the pan-Canadian Pharmaceutical Alliance (pCPA) Office, the body that provides dedicated centralized support to the national negotiating process for drug prices, representing all 14 public…
Taiho Pharmaceutical Co., Ltd. (TPC), Japan, part of Otsuka Holdings, established its Canadian affiliate in 2017. Ross Glover, general manager for Taiho Pharma Canada, has spent the past year tackling…
At the company’s 40th anniversary, Biogen’s Canadian head Marina Vasiliou gives an insight into her priorities as new managing director, her approach to building relationships with all stakeholders in the…
Looking back on his first year as CEO of Organigram, Greg Engel proudly highlights the successful transition of the company from being a low-cost to a high-quality cannabis producer with…
Still in the process of integration, Mallinckrodt is preparing to build its launch structure in Canada. With several innovative products in the pipeline, Robin Hunter, general manager of Canadian operations,…
Boston Scientific’s vice president and general manager Ken Spears shares his thoughts about the potential for Canada to become an early adopter of innovation and to move towards an outcome-based…
Hydropothecary is the leading medicinal cannabis producer in Quebec, founded in 2013 by two brothers-in-law, Sebastien St-Louis and Adam Miron. Terry Lake, former Minister of Health for British Colombia, discusses…
Upon opening an R&D center in Mississauga in 2017, Biolab Pharma Canada, headed by Paulo Wickbold Marques, became the first Brazilian pharmaceutical company to establish an affiliate in Canada. In…
Halo Pharma, a US-based one-stop-shop CDMO (Contract Development and Manufacturing Organization), operates out of a site in Mirabel, close to Montreal, that boasts 30 years of experience in developing and…
Boiron Canada is the sixth largest affiliate of Boiron’s global operations (in terms of sales), and under Daniel Dereser’s leadership, the company intends to change the perception of homeopathic medicine…
See our Cookie Privacy Policy Here